1. Home
  2. RFL vs RAND Comparison

RFL vs RAND Comparison

Compare RFL & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • RAND
  • Stock Information
  • Founded
  • RFL 2017
  • RAND 1969
  • Country
  • RFL United States
  • RAND United States
  • Employees
  • RFL N/A
  • RAND N/A
  • Industry
  • RFL Real Estate
  • RAND Finance: Consumer Services
  • Sector
  • RFL Finance
  • RAND Finance
  • Exchange
  • RFL Nasdaq
  • RAND Nasdaq
  • Market Cap
  • RFL 67.7M
  • RAND 57.6M
  • IPO Year
  • RFL N/A
  • RAND N/A
  • Fundamental
  • Price
  • RFL $2.13
  • RAND $17.43
  • Analyst Decision
  • RFL
  • RAND
  • Analyst Count
  • RFL 0
  • RAND 0
  • Target Price
  • RFL N/A
  • RAND N/A
  • AVG Volume (30 Days)
  • RFL 313.2K
  • RAND 4.8K
  • Earning Date
  • RFL 06-11-2025
  • RAND 08-05-2025
  • Dividend Yield
  • RFL N/A
  • RAND 9.82%
  • EPS Growth
  • RFL N/A
  • RAND 39.77
  • EPS
  • RFL N/A
  • RAND 3.12
  • Revenue
  • RFL $732,000.00
  • RAND $8,499,970.00
  • Revenue This Year
  • RFL N/A
  • RAND N/A
  • Revenue Next Year
  • RFL N/A
  • RAND N/A
  • P/E Ratio
  • RFL N/A
  • RAND $5.35
  • Revenue Growth
  • RFL 35.56
  • RAND 12.52
  • 52 Week Low
  • RFL $1.27
  • RAND $14.93
  • 52 Week High
  • RFL $3.19
  • RAND $31.89
  • Technical
  • Relative Strength Index (RSI)
  • RFL 61.68
  • RAND 69.52
  • Support Level
  • RFL $1.83
  • RAND $16.26
  • Resistance Level
  • RFL $2.04
  • RAND $16.89
  • Average True Range (ATR)
  • RFL 0.18
  • RAND 0.49
  • MACD
  • RFL 0.02
  • RAND 0.24
  • Stochastic Oscillator
  • RFL 55.44
  • RAND 100.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: